OBJECTIVE: Evaluation of single nucleotide polymorphisms (SNPs) in the interleukin-10 promoter (-592 and -819) on risk for death after burn injury. METHODS: Association between the IL-10 SNPs and outcome after burn injury was evaluated in a cohort of 265 patients from Parkland Hospital, Dallas, TX with ≥ 15% TBSA burns without non-burn trauma (ISS ≤ 16), traumatic or anoxic brain injury or spinal cord injury, who survived >48 h under an IRB-approved protocol. Clinical data were collected prospectively and genotyping was conducted by TaqMan assay. Whole blood from 31 healthy volunteers was stimulated with LPS (100 ng/mL) to determine the level of IL-10 expression for each allele by enzyme-linked immunosorbent assay (ELISA). RESULTS: After adjustment for percent total body surface area (TBSA) burned, inhalation injury, age, gender, and race/ethnicity, carriage of ‑592A and/or ‑819T was significantly associated (P = 0.014) with a decreased risk for death (adjusted odds ratio: 0.404; 95% CI: 0.197-0.829). As the candidate SNPs were in complete linkage disequilibrium, it was not possible to distinguish which allele was associated with decreased mortality risk. Age, inhalation injury, and full-thickness burn size were significantly associated with increased risk for death. In the LPS stimulated blood of healthy controls, carriage of the -592A and/or -819T allele demonstrated a trend for decreased levels of IL-10 (P = 0.079). CONCLUSION: Carriage of the ‑592A and/or ‑819T allele in the IL-10 promoter appears to reduce the risk for death after burn injury.
OBJECTIVE: Evaluation of single nucleotide polymorphisms (SNPs) in the interleukin-10 promoter (-592 and -819) on risk for death after burn injury. METHODS: Association between the IL-10 SNPs and outcome after burn injury was evaluated in a cohort of 265 patients from Parkland Hospital, Dallas, TX with ≥ 15% TBSA burns without non-burn trauma (ISS ≤ 16), traumatic or anoxic brain injury or spinal cord injury, who survived >48 h under an IRB-approved protocol. Clinical data were collected prospectively and genotyping was conducted by TaqMan assay. Whole blood from 31 healthy volunteers was stimulated with LPS (100 ng/mL) to determine the level of IL-10 expression for each allele by enzyme-linked immunosorbent assay (ELISA). RESULTS: After adjustment for percent total body surface area (TBSA) burned, inhalation injury, age, gender, and race/ethnicity, carriage of ‑592A and/or ‑819T was significantly associated (P = 0.014) with a decreased risk for death (adjusted odds ratio: 0.404; 95% CI: 0.197-0.829). As the candidate SNPs were in complete linkage disequilibrium, it was not possible to distinguish which allele was associated with decreased mortality risk. Age, inhalation injury, and full-thickness burn size were significantly associated with increased risk for death. In the LPS stimulated blood of healthy controls, carriage of the -592A and/or -819T allele demonstrated a trend for decreased levels of IL-10 (P = 0.079). CONCLUSION: Carriage of the ‑592A and/or ‑819T allele in the IL-10 promoter appears to reduce the risk for death after burn injury.
Authors: D K Amre; D R Mack; K Morgan; D Israel; P Lambrette; I Costea; A Krupoves; H Fegury; J Dong; G Grimard; C Deslandres; E Levy; E G Seidman Journal: Aliment Pharmacol Ther Date: 2009-02-07 Impact factor: 8.171
Authors: Sidney F Miller; Palmer Q Bessey; Michael J Schurr; Susan M Browning; James C Jeng; Daniel M Caruso; Manuel Gomez; Barbara A Latenser; Christopher W Lentz; Jeffrey R Saffle; Richard J Kagan; Gary F Purdue; John A Krichbaum Journal: J Burn Care Res Date: 2006 Jul-Aug Impact factor: 1.845
Authors: Celeste C Finnerty; David N Herndon; Rene Przkora; Clifford T Pereira; Hermes M Oliveira; Dulciene M M Queiroz; Andreia M C Rocha; Marc G Jeschke Journal: Shock Date: 2006-07 Impact factor: 3.454
Authors: David G Greenhalgh; Jeffrey R Saffle; James H Holmes; Richard L Gamelli; Tina L Palmieri; Jureta W Horton; Ronald G Tompkins; Daniel L Traber; David W Mozingo; Edwin A Deitch; Cleon W Goodwin; David N Herndon; James J Gallagher; Art P Sanford; James C Jeng; David H Ahrenholz; Alice N Neely; Michael S O'Mara; Steven E Wolf; Gary F Purdue; Warren L Garner; Charles J Yowler; Barbara A Latenser Journal: J Burn Care Res Date: 2007 Nov-Dec Impact factor: 1.845
Authors: D Olga McDaniel; James Hamilton; Marjolyn Brock; Warren May; Lynn Calcote; Lee Y Tee; Laura Vick; D Brian Newman; Kenneth Vick; Sebron Harrison; Gregory Timberlake; Christine Toevs Journal: J Trauma Date: 2007-07
Authors: Christopher S Davis; Scott E Janus; Michael J Mosier; Stewart R Carter; Jeffrey T Gibbs; Luis Ramirez; Richard L Gamelli; Elizabeth J Kovacs Journal: Ann Surg Date: 2013-06 Impact factor: 12.969
Authors: Christopher S Davis; Joslyn M Albright; Stewart R Carter; Luis Ramirez; Hajwa Kim; Richard L Gamelli; Elizabeth J Kovacs Journal: J Burn Care Res Date: 2012 Jan-Feb Impact factor: 1.845
Authors: Cressida Mahung; Wesley H Stepp; Clayton Long; Madison Malfitano; Irmak Saklayici; Shannon M Wallet; Laura Y Zhou; Haibo Zhou; Bruce A Cairns; Robert Maile Journal: J Trauma Acute Care Surg Date: 2022-03-30 Impact factor: 3.697
Authors: Joseph Beecham; Andrew Hart; Leo Alexandre; James Hernon; Bhaskar Kumar; Stephen Lam Journal: J Gastrointest Surg Date: 2019-07-03 Impact factor: 3.452
Authors: Fernando A Rivera-Chávez; Ryan M Huebinger; Agnes Burris; Ming-Mei Liu; Joseph P Minei; John L Hunt; Brett D Arnoldo; Robert C Barber Journal: ISRN Inflamm Date: 2013-02-12
Authors: Omar Nunez Lopez; Janos Cambiaso-Daniel; Ludwik K Branski; William B Norbury; David N Herndon Journal: Ther Clin Risk Manag Date: 2017-08-29 Impact factor: 2.423